|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9137 USD | +2.65% |
|
+48.33% | +27.43% |
| Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
| Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
VolitionRx Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 0.775302 million compared to USD 0.306392 million a year ago. Net loss was USD 35.32 million compared to USD 30.27 million a year ago.
Basic loss per share from continuing operations was USD 0.5 compared to USD 0.55 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +27.43% | 74.99M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
VOLITIONRX LIMITED 
